Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viviana Minardi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|November 6, 2007
Use of intrapleural bortezomib in myelomatous pleural effusionEmilio Iannitto, Viviana Minardi, Claudio Tripodo
Critical Reviews in Oncology/Hematology|August 8, 2008
Angioimmunoblastic T-cell lymphomaEmilio Iannitto, Andrés J M Ferreri, Viviana Minardi, et al.
European Journal of Haematology|March 20, 2013
Monoclonal antibodies: potential new therapeutic treatment against multiple myelomaAlessandro Allegra, Giuseppa Penna, Andrea Alonci, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|June 27, 2013
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximabAlessandro Allegra, Giacomo Oteri, Andrea Alonci, et al.
European Journal of Haematology|July 8, 2005
Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytesEmilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, et al.
Cancer|September 25, 2004
Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patientsEmilio Iannitto, Achille Ambrosetti, Emanuele Ammatuna, et al.
Archives of Internal Medicine|December 15, 2004
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparinsSergio Siragusa, Raffaela Anastasio, Camillo Porta, et al.
European Journal of Haematology|February 8, 2005
Hepatitis B virus reactivation and alemtuzumab therapyEmilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, et al.
European Journal of Haematology|January 13, 2006
Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphomaEmilio Iannitto, Viviana Minardi, Vincenzo Callea, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trialEmilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|November 6, 2007
Use of intrapleural bortezomib in myelomatous pleural effusionEmilio Iannitto, Viviana Minardi, Claudio Tripodo
Critical Reviews in Oncology/Hematology|August 8, 2008
Angioimmunoblastic T-cell lymphomaEmilio Iannitto, Andrés J M Ferreri, Viviana Minardi, et al.
European Journal of Haematology|March 20, 2013
Monoclonal antibodies: potential new therapeutic treatment against multiple myelomaAlessandro Allegra, Giuseppa Penna, Andrea Alonci, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|June 27, 2013
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximabAlessandro Allegra, Giacomo Oteri, Andrea Alonci, et al.
European Journal of Haematology|July 8, 2005
Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytesEmilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, et al.
Cancer|September 25, 2004
Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patientsEmilio Iannitto, Achille Ambrosetti, Emanuele Ammatuna, et al.
Archives of Internal Medicine|December 15, 2004
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparinsSergio Siragusa, Raffaela Anastasio, Camillo Porta, et al.
European Journal of Haematology|February 8, 2005
Hepatitis B virus reactivation and alemtuzumab therapyEmilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, et al.
European Journal of Haematology|January 13, 2006
Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphomaEmilio Iannitto, Viviana Minardi, Vincenzo Callea, et al.
Clinical Lymphoma & Myeloma|May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trialEmilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.
Pageof 2